fig6

Taxonomic and mechanistic insights into gut microbiota bioaccumulation of entacapone using bioorthogonal drug labelling

Figure 6. Identification of molecular determinants of entacapone accumulation in E. coli. (A) Microscopy images showing the interaction of EB-11-24 with E. coli BW25113, BW25113 ΔfepA, and an E. coli gut isolate (termed DIEC), isolated from ED01. Images were acquired using a 100× oil immersion objective with a fluorescence exposure time of 429 ms, for all samples. Scale bar: 50 µm; (B) Boxplots display background-corrected, SYTO-normalised azide fluorescence intensities in the three bacterial strains shown in A, measured on a plate well using a plate reader. Each point represents a technical replicate, with three technical replicates and three biological replicates analysed for each E. coli strain (n = 9); samples are color-coded by biological replicate. Boxes represent the interquartile range (IQR), with horizontal lines indicating the median; whiskers extend to 1.5× the IQR. Jittered points depict within-group variability. Statistical significance was assessed by one-way ANOVA (overall P-value shown), followed by pairwise comparisons using the Wilcoxon test with Benjamini-Hochberg correction. Significance levels: **** P < 0.0001, *** P < 0.001, * P < 0.05. E. coli: Escherichia coli.

Microbiome Research Reports
ISSN 2771-5965 (Online)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/